DRUG · Unmapped registry intervention
Repaglinide and Insulin
Find medicine records ·
Find other trials using this name
Clinical trial
Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
NCT00231192
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedRepaglinide for Adolescents With Cystic Fibrosis-Related Diabetes
Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetesverified · MONDO: diabetes mellitus
Interventions
Sponsors & collaborators
Children's Hospital of Philadelphialead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00231192 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.